Gambia | Ghana | Kenya | Nigeria | Uganda | |
---|---|---|---|---|---|
Artemisinin-combination theraphy | |||||
artemether_amiodaquine | - | - | - | 0%(0%, 1%) | - |
artemether_lumefantrine | - | 4%(-1%) | 30%(21%,39%) | 8%(4%,11%) | 36%(26%,46%) |
artesunate_amodiaquine | - | 32%(21%,42%) | - | 0%(0%,1%) | - |
artesunate_mefloquine | - | - | 0%(0%,1%) | - | - |
dihydroartemisinin_piperaquine | - | 5%(1%,9%) | 0%(0%,1%) | - | 1%(0%,2%) |
Other Antimalarials | |||||
SP | 64%(54%,74%) | 4%(0%,7%) | 13%(6%,20%) | 9%(3%,15%) | 9%(6%,13%) |
chloroquine | 97%(95%,100%) | 8%(1%,16%) | 1%(0%,2%) | 39%(29%,48%) | 18%(12%,24%) |
amodiaquine | - | 21%(13%,29%) | 13%(8%,18%) | 0%(0%,1%) | 4%(1%,7%) |
antimalarial, unspecified | - | 19%(11%,27%) | 33%(25%,42%) | 38%(27%,48%) | 24%(13%,35%) |
quinine | 1%(0%,1%) | 4%(-1%,8%) | 11%(6%,15%) | 1%(0%,3%) | 21%(17%,25%) |
artemether | - | 3%(0%,5%) | - | 3%(0%,6%) | 1%(0%,1%) |
artemisinin | - | - | 1%(0%,2%) | 1%(0%,2%) | - |
artesunate | - | 9%(4%,14%) | - | 5%(2%,8%) | - |
chloroquine_SP | 1%(0%,2%) | - | - | - | 0%(0%,1%) |
dihydroartemisinin | - | - | 2%(0%,3%) | 1%(0%,1%) | - |
halofantrine | - | - | - | 1%(0%,2%) | - |
mefloquine | - | - | - | 0%(0%,1%) | - |
quinine_SP | - | - | 2%(0%,3%) | - | - |